SG10201501579WA - Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation - Google Patents
Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiationInfo
- Publication number
- SG10201501579WA SG10201501579WA SG10201501579WA SG10201501579WA SG10201501579WA SG 10201501579W A SG10201501579W A SG 10201501579WA SG 10201501579W A SG10201501579W A SG 10201501579WA SG 10201501579W A SG10201501579W A SG 10201501579WA SG 10201501579W A SG10201501579W A SG 10201501579WA
- Authority
- SG
- Singapore
- Prior art keywords
- hydroxykynurennine
- carnitine
- glucoside
- pathologies
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10155501A EP2363126A1 (en) | 2010-03-04 | 2010-03-04 | Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201501579WA true SG10201501579WA (en) | 2015-04-29 |
Family
ID=42330662
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201501579WA SG10201501579WA (en) | 2010-03-04 | 2011-02-10 | Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
| SG2012058301A SG183201A1 (en) | 2010-03-04 | 2011-02-10 | Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012058301A SG183201A1 (en) | 2010-03-04 | 2011-02-10 | Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20130045940A1 (en) |
| EP (2) | EP2363126A1 (en) |
| JP (1) | JP2013521240A (en) |
| KR (1) | KR20130014503A (en) |
| CN (1) | CN102753163B (en) |
| AU (1) | AU2011223177A1 (en) |
| BR (1) | BR112012022074A2 (en) |
| CA (1) | CA2788865A1 (en) |
| EA (1) | EA201201239A1 (en) |
| MX (1) | MX2012009471A (en) |
| SG (2) | SG10201501579WA (en) |
| WO (1) | WO2011107334A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7897734B2 (en) | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
| JP6150510B2 (en) * | 2011-12-12 | 2017-06-21 | ロート製薬株式会社 | Ophthalmic aqueous composition |
| JP6081173B2 (en) * | 2011-12-12 | 2017-02-15 | ロート製薬株式会社 | Ophthalmic aqueous composition |
| IL225179A (en) * | 2013-03-12 | 2017-01-31 | Rogosnitzky Moshe | Compositions for use in treating eye disorders using dipyridamole |
| US9254289B2 (en) * | 2013-03-13 | 2016-02-09 | Remedeye Inc. | Methods for treating eye disorders using dipyridamole |
| US20150031712A1 (en) * | 2013-03-12 | 2015-01-29 | Moshe Rogosnitzky | Therapeutic Compositions Containing Dipyridamole and Treatment Packs Including Such Compositions and Methods for Producing Same |
| TWI658828B (en) * | 2014-10-31 | 2019-05-11 | 中國醫藥大學 | Pharmaceutical composition for soothing and reducing myopia, and preparation method and application thereof |
| CN110172373B (en) * | 2019-06-14 | 2022-08-05 | 中国农业科学院农产品加工研究所 | Application of resveratrol in peanut oil |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1156852B (en) | 1978-07-10 | 1987-02-04 | Sigma Tau Ind Farmaceuti | INDUSTRIAL PROCEDURE FOR THE PREPARATION OF THE L CARNITINAMIDE D'CANFORATE AND THE D CARNITINAMIDE D CANPHORATE AND ITS APPLICATIONS |
| IT1235153B (en) | 1988-11-15 | 1992-06-22 | Sigma Tau Ind Farmaceuti | USE OF ACETYL L-CARNITINE IN THE THERAPEUTIC TREATMENT OF CATARACT AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT |
| IT1224795B (en) | 1988-12-01 | 1990-10-24 | Sigma Tau Ind Farmaceuti | USE OF ACETYL D-CARNITINE IN THE THERAPEUTIC TREATMENT OF GLAUCOMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT |
| IT1288399B1 (en) | 1996-12-03 | 1998-09-22 | Sigma Tau Ind Farmaceuti | MEDICATION FOR THE THERAPEUTIC TREATMENT OF AGE-RELATED MACULOPATHY, NON-AGE-RELATED MACULOPATHY AND FOR PROPHYLAXIS |
| WO1998053806A1 (en) | 1997-05-26 | 1998-12-03 | New Vision Co., Ltd. | Medicinal compositions for topical administration containing vitamin d and vitamin k |
| US6825975B2 (en) | 2002-08-27 | 2004-11-30 | Photoprotective Technologies, Inc. | Light filters using the oxidative polymerization product of 3-Hydroxykynurenine (3-OHKyn) |
| IL168603A (en) * | 2005-05-16 | 2011-05-31 | Resdevco Res And Dev Co | Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells |
| AU2006265248B2 (en) * | 2005-07-01 | 2011-12-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| WO2008077712A1 (en) | 2006-12-22 | 2008-07-03 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Gel useful for the delivery of ophthalmic drugs |
-
2010
- 2010-03-04 EP EP10155501A patent/EP2363126A1/en not_active Withdrawn
-
2011
- 2011-02-10 SG SG10201501579WA patent/SG10201501579WA/en unknown
- 2011-02-10 US US13/576,104 patent/US20130045940A1/en not_active Abandoned
- 2011-02-10 EP EP11702470A patent/EP2542233A1/en not_active Withdrawn
- 2011-02-10 AU AU2011223177A patent/AU2011223177A1/en not_active Abandoned
- 2011-02-10 CA CA2788865A patent/CA2788865A1/en not_active Abandoned
- 2011-02-10 EA EA201201239A patent/EA201201239A1/en unknown
- 2011-02-10 KR KR1020127022768A patent/KR20130014503A/en not_active Application Discontinuation
- 2011-02-10 WO PCT/EP2011/051941 patent/WO2011107334A1/en active Application Filing
- 2011-02-10 JP JP2012555349A patent/JP2013521240A/en active Pending
- 2011-02-10 BR BR112012022074A patent/BR112012022074A2/en not_active IP Right Cessation
- 2011-02-10 MX MX2012009471A patent/MX2012009471A/en active IP Right Grant
- 2011-02-10 SG SG2012058301A patent/SG183201A1/en unknown
- 2011-02-10 CN CN201180008460.3A patent/CN102753163B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012022074A2 (en) | 2016-06-14 |
| EP2542233A1 (en) | 2013-01-09 |
| CA2788865A1 (en) | 2011-09-09 |
| MX2012009471A (en) | 2012-10-09 |
| CN102753163B (en) | 2015-04-01 |
| EP2363126A1 (en) | 2011-09-07 |
| SG183201A1 (en) | 2012-10-30 |
| US20130045940A1 (en) | 2013-02-21 |
| CN102753163A (en) | 2012-10-24 |
| JP2013521240A (en) | 2013-06-10 |
| KR20130014503A (en) | 2013-02-07 |
| WO2011107334A1 (en) | 2011-09-09 |
| AU2011223177A1 (en) | 2012-08-30 |
| EA201201239A1 (en) | 2013-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181364T8 (en) | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof | |
| ZA201304638B (en) | Composition for use in the prevention and /or treatment of skin condition and skin diseases. | |
| SG10201501579WA (en) | Composition comprising as active ingredient l-carnitine in combination with hydroxykynurennine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation | |
| IL231536A (en) | Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases | |
| IL216800A (en) | Composition for the treatment of dry eye syndrome | |
| EP2528603A4 (en) | Pharmaceutical compositions for the treatment of pain and other indicatons | |
| ZA201208413B (en) | Skin treatment composition | |
| HK1167348A1 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| IL223289A (en) | Triazine derivatives and pharmaceutical compositions comprising them for the treatment of type 2 diabetes | |
| IL221273A0 (en) | Combination composition comprising as active ingredient l- carnitine or propionyl l-carnitine for the prevention or treatment of chronic venous insufficiency | |
| HUP1000362A2 (en) | Antiseptic and disinfecting compositions having reduced iodine content | |
| HUE044715T2 (en) | Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions | |
| ZA201402452B (en) | Novel pyrimethanil formulations and uses thereof in the treatment of crops | |
| HK1198632A1 (en) | Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field no- | |
| ZA201208568B (en) | Skin treatment composition | |
| HK1214771A1 (en) | Formulations for use in the treatment of skin conditions | |
| LT2699545T (en) | Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome | |
| EP2902024A4 (en) | Synergic composition of nitazoxanide and mebendazole, methods for the preparation thereof, and use of said composition for the treatment of human parasitosis | |
| IL223219A0 (en) | Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies | |
| HK1188565A1 (en) | Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans | |
| HUE040124T2 (en) | Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain | |
| ZA201206518B (en) | Combination composition,comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insuficiency | |
| GB0911581D0 (en) | Compositions for use in the treatment of dry eye |